Overall, PCAT19 demonstrates context-dependent roles in lung cancer, acting as an oncogene in NSCLC by inhibiting p53 and as a tumor suppressor in LUAD by acting as ceRNA dynamics. This evidence concerns the gene TP53 and neoplasm.